GNT0004, Genethon’s AAV8 vector-delivered microdystrophin gene therapy of Duchenne muscular dystrophy, first data of the phase I/II part of the GNT-016-MDYF all-in-one clinical trial in ambulant boys

2024

Laugel V et Al.

Neuromuscular Disorders 43, 410

Lire l'article